TABLE 1.
Gene Investigated | Study Design | Case/Control Size | Strength of HNSCC Association OR (95 % CI) |
Subgroup Stratification |
---|---|---|---|---|
XRCC1 R194W (Homozygous) | Meta-analysis of 30 Studies (Flores-Obando et al16) | 7,291/12,052 | 1.78 (1.13–2.82) | Asians |
Meta-analysis of 29 Studies (Lou et al17) | 6,719/9,627 | 0.91 (0.77–1.08) | N/A (Total Population) | |
2.53 (1.16–5.53) | Smokers | |||
XRCC1 R399Q (Homozygous & Heterozygous) | Meta-analysis of 30 Studies (Flores-Obando et al16) | 7,291/12,052 | 1.14 (1.01–1.27) | Caucasians |
Meta-analysis of 29 Studies (Lou et al17) | 6,719/9,627 | 0.99 (0.90–1.09) | N/A (Total Population) | |
0.7 (0.43–1.15) | Smokers | |||
XPD D312N (Heterozygous) | Meta-analysis of 30 Studies (Flores-Obando et al16) | 7,291/12,052 | 1.14 (1.01–1.29) | N/A (Total Population) |
Meta-analysis of 9 Studies (Hu et al18) | 2,670/4,452 | 1.11 (0.99–1.24) | N/A (Total Population) | |
HEL308 (Homozygous & Heterozygous) | GWAS of European Studies in INHANCE Consortium (McKay et al19) | 8,605/16,226 | 1.13 (1.08–1.17) | N/A (Total Population) |
1.19 (1.08–1.31) | Age < 50 Years | |||
1.03 (0.93–1.14) | Never smokers | |||
1.04 (0.93–1.18) | Never drinkers | |||
HEL308 (Homozygous) | Case-Control Study of Patients in the Boston, MA Area (Liang et al21) | 575/676 | 0.78 (0.57–1.06) | N/A (Total Population) |
Case-Control Study of Chinese Nationals (Yuan et al22) | 397/900 | 0.98 (0.82–1.18) | N/A (Total Population) |